X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-11-01 | CLSD | Chong Ngai Hang Victor | CHIEF MEDICAL OFFICER | P - Purchase | $1.00 | +36,500 | 100,000 | +57% | +$36,500 | ||||||
2024-06-24 | CLSD | Chong Ngai Hang Victor | CHIEF MEDICAL OFFICER | P - Purchase | $1.06 | +23,500 | 63,500 | +59% | +$24,910 | ||||||
2024-05-15 | CLSD | Yerxa Benjamin R | Dir | P - Purchase | $1.31 | +7,813 | 17,957 | +77% | +$10,235 | ||||||
| M | 2024-04-17 | CLSD | Gibney Anthony S | Dir | P - Purchase | $1.30 | +100,000 | 100,000 | New | +$129,665 | |||||
2024-03-20 | CLSD | Chong Ngai Hang Victor | CHIEF MEDICAL OFFICER | P - Purchase | $1.60 | +30,000 | 30,000 | New | +$48,000 | ||||||
| D | 2024-02-07 | CLSD | Whitmore Bradford T | 10% | P - Purchase | $1.35 | +444,444 | 6,845,186 | +7% | +$599,999 | |||||
| D | 2024-01-19 | CLSD | Lasezkay George M | CEO | S - Sale+OE | $1.27 | -18,000 | 466,577 | -4% | -$22,860 | |||||
| D | 2024-01-19 | CLSD | Deignan Charles A. | CFO | S - Sale+OE | $1.28 | -12,900 | 384,662 | -3% | -$16,512 | |||||
| M | 2023-10-30 | CLSD | Whitmore Bradford T | 10% | P - Purchase | $0.74 | +135,778 | 6,400,742 | +2% | +$99,849 | |||||
2023-10-03 | CLSD | Hutson Nancy J | Dir | P - Purchase | $0.86 | +10,000 | 93,000 | +12% | +$8,600 | ||||||
2023-09-25 | CLSD | Thorp Clay | Dir | P - Purchase | $0.86 | +10,000 | 3,585,562 | 0% | +$8,600 | ||||||
2023-01-20 | CLSD | Ciulla Thomas | Chief Medical Officer | S - Sale | $1.47 | -13,700 | 291,890 | -4% | -$20,139 | ||||||
2023-01-19 | CLSD | Lasezkay George M | CEO | S - Sale | $1.46 | -20,030 | 484,577 | -4% | -$29,244 | ||||||
2023-01-19 | CLSD | Deignan Charles A. | CFO | S - Sale | $1.50 | -14,030 | 363,472 | -4% | -$21,045 | ||||||
2023-01-10 | CLSD | Ciulla Thomas | Chief Medical Officer | S - Sale | $1.62 | -2,170 | 305,590 | -1% | -$3,515 | ||||||
2022-12-21 | CLSD | Thorp Clay | Dir | P - Purchase | $1.02 | +14,000 | 3,575,562 | 0% | +$14,266 | ||||||
| A | 2021-02-10 | CLSD | Thorp Clay | Dir | S - Sale | $4.43 | -32,873 | 4,951,547 | -1% | -$145,627 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |